Blog

FDA panel considers gene therapy for blindness – SFGate


SFGate

FDA panel considers gene therapy for blindness
SFGate
It would be the first gene therapy in the U.S. for an inherited disease, and the first in which a corrective gene is given directly to a patient. Only one gene therapy is sold in the U.S. now, a cancer treatment approved in August. Children, parents
FDA may approve gene therapy that could cure hereditary blindnessAtlanta Journal Constitution



all 7 news articles »

2017-10-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.